Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Sab Biotherapeutics, Inc. (SABS) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Sab Biotherapeutics, Inc. (SABS) lobbying for?
Summary of Sab Biotherapeutics’ lobbying data:
– Lobbying firms hired: Arentfox Schiff Llp, Dla Piper Llp (Us)
– General issues lobbied on: Pharmacy, Budget/Appropriations, Health Issues
– Specific issues lobbied on: Federal contracts for biopharmaceuticals development., PREVENT Pandemics Act., Provisions relating to the manufacturing priorities for biopharmaceuticals., Federal contracts for biopharmaceuticals development. S. 3799, Biomedical research funding programs within Department of Health and Human Services and Department of Defense, Food and Drug Administration policies regarding therapeutics
– Government agencies lobbied: Senate, House of Representatives
One could infer that Sab Biotherapeutics is lobbying on pharmacy, budget/appropriations, and health issues related to biopharmaceuticals development, biomedical research funding programs, and Food and Drug Administration policies regarding therapeutics in order to advance their business interests in these areas. Sab Biotherapeutics is a biotechnology company that develops novel human antibody therapeutics using their proprietary DiversitAb platform. By lobbying government agencies and lawmakers, the company may be seeking to influence policies and funding decisions that could potentially benefit their research and development efforts, as well as the manufacturing and distribution of their products. Additionally, their lobbying on the PREVENT Pandemics Act suggests that the company is also interested in pandemic preparedness and response issues, potentially related to their development of next-generation immunotherapies.
